Tag: Drug pricing
Maryland Governor Signs Law Expanding State’s Prescription Drug Affordability Board Powers
In a pretty big deal, Maryland Gov. Wes Moore went ahead and signed this bill that lets a state board keep working on making prescription drugs cheaper for everyone in the state, not just...
Criticism from Industry Group on UK Drug Rebate Increase
U.K. Industry Group Criticizes Drug Rebate Increase ProposalA recent government proposal in the U.K. to raise mandatory rebates for drug companies aimed at supporting the National Health Service (NHS) has sparked intense criticism from...
Analyzing UnitedHealth Buyouts and Drug Pricing Strategies
UnitedHealth Group recently made headlines with their announcement of buyout offers for employees working in the UnitedHealthcare insurance division. The company described the buyouts as a "great opportunity" during an employee webinar where executives...
Maryland Lawmakers Vote to Expand Prescription Drug Affordability Board
In a groundbreaking move, Maryland lawmakers have cast a decisive vote to expand the powers of the Prescription Drug Affordability Board. This decision will enable the board to extend its reach beyond government employees...
Generic Drugmakers Prevail in California Pay-to-Delay Ban Battle
In a recent turn of events, a federal judge has ruled in favor of generic drugmakers in California's battle against pay-to-delay agreements. This controversial law, enacted in 2019, aimed to ban such deals between...
Threat to Pharmaceutical Public-Private Partnerships: Gilead’s Short-Term Win
In December 2024, a group of legal, medical, and public health experts united to file an amicus brief in support of the U.S. government in a groundbreaking patent lawsuit against Gilead Sciences Inc., a...
Impact of U.S. Election on Medicare, Drug Pricing, and AI
Health care is a significant topic in the upcoming U.S. election, with leaders from different political backgrounds sharing their views on various health care issues at STAT's Summit. Among the topics discussed were Medicare,...
New Title: Soft-Tissue Cancer Drug Approval and Zepbound Shortage Update: Pharmalittle News
Good morning, this is Jonathan Wosen, reporting on the latest news in the biotech and life sciences world. The FDA has recently approved a new treatment for a rare soft tissue cancer. This cutting-edge...